Bontemps H - Search Results

1

Implementation of a documentation management system for quality assurance in a university hospital.

François P, Labarère J, Bontemps H, Weil G, Calop J. François P, et al. Among authors: bontemps h. Int J Health Care Qual Assur Inc Leadersh Health Serv. 1997;10(4-5):156-60. doi: 10.1108/09526869710189333. Int J Health Care Qual Assur Inc Leadersh Health Serv. 1997. PMID: 10173354

2

Evaluation of prescription-writing quality in a French university hospital.

François P, Chirpaz E, Bontemps H, Labarère J, Bosson JL, Calop J. François P, et al. Among authors: bontemps h. Clin Perform Qual Health Care. 1997 Jul-Sep;5(3):111-5. Clin Perform Qual Health Care. 1997. PMID: 10169181

3

[Study of the quality of prescribing drugs in hospitals].

François P, Bontemps H, Bertrand D, Bosson JL, Calop J. François P, et al. Among authors: bontemps h. Therapie. 1997 Nov-Dec;52(6):569-71. Therapie. 1997. PMID: 9734109 French.

4

[Adverse effects and medication errors: incidence and role of the organization of drug distribution].

Piquet C, Mallaret M, Bontemps H, Fabre M, Sarrot-Reynaud F, Imbert B. Piquet C, et al. Among authors: bontemps h. Therapie. 1999 Jan-Feb;54(1):49-53. Therapie. 1999. PMID: 10216422 French.

5

[Prescription of acetaminophen in five French hospitals: What are the practices?].

Pace JB, Nave V, Moulis M, Bourdelin M, Coursier S, Jean-Bart É, Leroy B, Bonnefous JL, Bontemps H, Coutet J, Eyssette C, Pont E. Pace JB, et al. Among authors: bontemps h. Therapie. 2017 Oct;72(5):579-586. doi: 10.1016/j.therap.2017.01.007. Epub 2017 Feb 22. Therapie. 2017. PMID: 28336157 French.

6

[Targeting high-risk drugs to optimize clinical pharmacists' intervention].

Mouterde AL, Bourdelin M, Maison O, Coursier S, Bontemps H. Mouterde AL, et al. Among authors: bontemps h. Therapie. 2016 Dec;71(6):595-603. doi: 10.1016/j.therap.2016.06.002. Epub 2016 Jun 22. Therapie. 2016. PMID: 27475957 French.

7

[Dysthyroidism with anti-VEGF treatment, a class effect? about one case report].

Khouri C, Jean Bart E, Logerot S, Decker-Bellaton A, Bontemps H, Mallaret M. Khouri C, et al. Among authors: bontemps h. Therapie. 2014 Nov-Dec;69(6):521-4. doi: 10.2515/therapie/2014063. Epub 2014 Oct 9. Therapie. 2014. PMID: 25293486 French.

8

Dysthyroidie sous anti-VEGF, effet indésirable de classe ? À propos d'un cas.

Khouri C, Bart EJ, Logerot S, Decker-Bellaton A, Bontemps H, Mallaret M. Khouri C, et al. Among authors: bontemps h. Therapie. 2014 Nov-Dec;69(6):521-4. doi: 10.2515/therapie/2014063. Therapie. 2014. PMID: 27392902 French.

9

[Economic impact of pharmacist's interventions: illustration in a rheumatology ward].

Coursier S, Bontemps H, Brantus JF, Allenet B. Coursier S, et al. Among authors: bontemps h. J Pharm Belg. 2008 Dec;63(4):103-9. J Pharm Belg. 2008. PMID: 19320133 French.

10

[Audits of good practice: implantable medical devices are also concerned].

Leroy B, Berry J, Coursier S, Martelet S, Poulain C, Bontemps H, Berthonnaud E. Leroy B, et al. Among authors: bontemps h. Ann Pharm Fr. 2012 Sep;70(5):298-305. doi: 10.1016/j.pharma.2012.07.004. Epub 2012 Aug 16. Ann Pharm Fr. 2012. PMID: 23020921 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters